Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Auxly Cannabis Group's enterprise value is $250.8 Mil.
Auxly Cannabis Group's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was $34.3 Mil. Therefore, Auxly Cannabis Group's EV-to-EBITDA for today is 7.30.
The historical rank and industry rank for Auxly Cannabis Group's EV-to-EBITDA or its related term are showing as below:
CBWTF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -61.51 Med: -4.87 Max: 83.81
Current: 7.3
During the past 13 years, the highest EV-to-EBITDA of Auxly Cannabis Group was 83.81. The lowest was -61.51. And the median was -4.87.
CBWTF's EV-to-EBITDA is ranked better than 74.66% of 730
companies
in the Drug Manufacturers industry
Industry Median: 13.47
vs CBWTF: 7.30
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Auxly Cannabis Group (OTCPK:CBWTF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Auxly Cannabis Group's PE Ratio (TTM) for today is calculated as:
Auxly Cannabis Group's share price for today is $2.323.
Auxly Cannabis Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.151.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Auxly Cannabis Group's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Auxly Cannabis Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Auxly Cannabis Group EV-to-EBITDA vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Auxly Cannabis Group's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Auxly Cannabis Group's EV-to-EBITDA falls into.
Auxly Cannabis Group's current Enterprise Value is $250.8 Mil.
Auxly Cannabis Group's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $34.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Auxly Cannabis Group (CBWTF) has a EV-to-EBITDA of 7.30 as of Aug. 30, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Auxly Cannabis Group. According to the industry distribution chart, Auxly Cannabis Group ranks #185 out of 730 companies in the Drug Manufacturers industry, placing it in the top 25.3%.
Is Auxly Cannabis Group's EV-to-EBITDA too high?
Auxly Cannabis Group's current EV-to-EBITDA is 7.30. The Drug Manufacturers industry median EV-to-EBITDA is 13.47. Auxly Cannabis Group's value of 7.30 is 45.8% below this industry median. Based on the distribution chart, Auxly Cannabis Group ranks #185 out of 730 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Auxly Cannabis Group has a GF Score™ of 37/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Auxly Cannabis Group's EV-to-EBITDA compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Auxly Cannabis Group ranks #185 out of 730 companies for EV-to-EBITDA. This puts Auxly Cannabis Group in the upper half of its industry. The industry median EV-to-EBITDA is 13.47. Auxly Cannabis Group's value of 7.30 is 45.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Drug Manufacturers company?
The median EV-to-EBITDA among Drug Manufacturers companies is 13.47, based on 730 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Auxly Cannabis Group's current EV-to-EBITDA of 7.30 is 45.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Auxly Cannabis Group. For the Drug Manufacturers industry, the median EV-to-EBITDA is 13.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Auxly Cannabis Group's current EV-to-EBITDA is 7.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Auxly Cannabis Group stock overvalued right now?
Based on GuruFocus' analysis, Auxly Cannabis Group (CBWTF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.63, compared to a current price of $2.32 — trading 268.7% above its estimated fair value. The current EV-to-EBITDA is 7.30 and 45.8% below the Drug Manufacturers industry median of 13.47. Auxly Cannabis Group's overall GF Score™ is 37/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Auxly Cannabis Group (CBWTF), the current EV-to-EBITDA is 7.30 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Auxly Cannabis Group (CBWTF) Overvalued in 2026?
Based on GuruFocus' analysis, Auxly Cannabis Group stock appears to be overvalued.
The current stock price of $2.32 is trading 268.7% above its estimated GF Value™ of $0.63.
GuruFocus considers Auxly Cannabis Group to be Significantly Overvalued.
Key valuation signals for CBWTF:
EV-to-EBITDA: 7.30
GF Value™: $0.63 vs. price of $2.32 (268.7% above fair value)
Industry Position: 45.8% below the Drug Manufacturers median (#185 of 730)
No single metric tells the full story. See the CBWTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Auxly Cannabis Group Inc is a consumer-packaged-goods company in the cannabis products market. The company has created a portfolio of brands designed for a broad market of cannabis consumers, with differentiation in price points across targeted consumer segments. Its product portfolio comprises dried cannabis, fresh cannabis, cannabis plants, cannabis seeds, cannabis oil, edible cannabis, cannabis extracts, and cannabis topicals, among others, which are marketed through brands like Parcel, Black Forty, Foray, Dosecann, and Kolab Project.
37GF Score
Get the complete analysis for CBWTF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CBWTF has been successfully added to your 
